Financial results of IBL Healthcare Limited for Quarter ended December 31, 2017

Financial Results

Karachi, IBL Healthcare Limitedinformed Pakistan Stock Exchange about the recommendations made by the board of directors in the meeting held at Karachi on February 20, 2018.

The agenda of the meeting was discussion of profit and loss account for quarter ended December 31, 2017 which portrayed a profit of Rs. 27,086 with earnings per share 0.50 basic and diluted respectively.

Further, nil payment of cash dividend, bonus shares and right shares was agreed.

The company was incorporated in Pakistan as a private limited company on July 14, 1997. In November 2008 the Company was converted into a public limited company. The foundations of the company are laid under the Companies Ordinance, 1984. The company is a wholly owned subsidiary of Searle Pakistan Limited. The principal business activities of the company are marketing and selling, distribution of healthcare products. The shares of the company are quoted on the Karachi Stock Exchange. The registered office of the company is located in Karachi.

The portfolio of the company includes divided into three distinct categories, namely Nutritional Products, Plasma Protein Components and Hospital Disposables. The company is the major partner of globally recognized multinational organizations having expertise in their respective fields of health care products. The partners of the company include MeadJohnson Nutritionals – USA, Tyco Health Care – USA, Intersurgical – UK, Terumo – Japan and Molnlycke – Sweden.

The symbol “IBLHL” is being used by the stock exchanges for the shares of IBL Healthcare Limited.